Candida Kassuya

Prof. Candida Kassuya

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
KNKamilla Felipe Do Nascimento
Kamilla Felipe Do Nascimento
FMFlora Martinez Figueira Moreira
Flora Martinez Figueira Moreira
JSJoyce Alencar Santos
Joyce Alencar Santos
CKCandida Kassuya
Candida Kassuya
JCJulio Henrique Rosa Croda
Julio Henrique Rosa Croda
AFAnelise Formagio
Anelise Formagio

1 May 2005 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
JCJ Calixto
J Calixto
CKCandida Kassuya
Candida Kassuya
EAE Andre
E Andre
JFJ Ferreira
J Ferreira

1 March 2011 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior
FGFrancielly Mourão Gasparotto
Francielly Mourão Gasparotto
ELEmerson Luiz Botelho Lourenço
Emerson Luiz Botelho Lourenço
SCSandra Crestani
Sandra Crestani
MSMaria Elida Alves Stefanello
Maria Elida Alves Stefanello
CKCandida Kassuya
Candida Kassuya

1 February 2006 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
PDF file
FMFlavia Carla Meotti
Flavia Carla Meotti
ALAna Paula Luiz
Ana Paula Luiz
MPMoacir Geraldo Pizzolatti
Moacir Geraldo Pizzolatti
CKCandida Kassuya
Candida Kassuya
JCJoão B. Calixto
João B. Calixto
ASAdair R. S. Santos
Adair R. S. Santos
The present study investigated the antinociceptive effects of the flavonoid myricitrin in chemical behavioral models of pain in mice and rats. Myricitrin given by i.p. or p.o. routes produced dose-related antinociception when assessed on acetic acid-induced visceral pain in mice. In addition, the i.p. administration of myricitrin exhibited significant inhibition of the neurogenic pain induced by intraplantar (i.pl.) injection of capsaicin. Like-wise, myricitrin given by i.p. route reduced the nociception produced by i.pl. injection of glutamate and phorbol myristate acetate (PMA). Western blot analysis revealed that myricitrin treatment fully prevented the protein kinase C (PKC) α and PKCϵ activation by PMA in mice hind paws. Myricitrin given i.p. also inhibited the mechanical hyperalgesia induced by bradykinin, without affecting similar responses caused by epinephrine and prostaglandin E2. The antinociception caused by myricitrin in the acetic acid test was significantly attenuated by i.p. treatment of mice with the nitric oxide precursor, l-arginine. In contrast, myricitrin antinociception was not affected by naloxone (opioid receptor antagonist) or neonatal pretreatment of mice with capsaicin and myricitrin antinociceptive effects is not related to muscle relaxant or sedative action. Together, these results indicate that myricitrin produces pronounced antinociception against chemical and mechanical models of pain in rodents. The mechanisms involved in their actions are not completely understood but seem to involve an interaction with nitric oxide-l-arginine and protein kinase C pathways.

1 November 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
LTLucas Noboru Fatori Trevizan
Lucas Noboru Fatori Trevizan
KNKamilla Felipe Do Nascimento
Kamilla Felipe Do Nascimento
JSJoyce Alencar Santos
Joyce Alencar Santos
CKCandida Kassuya
Candida Kassuya
Claudia Andrea Lima CardosoClaudia Andrea Lima Cardoso
Claudia Andrea Lima Cardoso
AFAnelise Formagio
Anelise Formagio

1 July 2005 in Planta Medica
Verified
Journal Article
Closed access
PDF file
CKCandida Kassuya
Candida Kassuya
DLDaniela F. P. Leite
Daniela F. P. Leite
LMLucilia Vilela de Melo
Lucilia Vilela de Melo
VRVera Lúcia G. Rehder
Vera Lúcia G. Rehder
JCJoão B. Calixto
João B. Calixto
This study assessed the anti-inflammatory effect of the extracts and purified lignans obtained from Phyllanthus amarus. Given orally, the hexane extract (HE), the lignan-rich fraction (LRF), or the lignans phyltetralin, nirtetralin, niranthin, but not hypophyllanthin or phyllanthin, inhibited carrageenan (Cg)-induced paw oedema and neutrophil influx. The HE, the LRF or nirtetralin also inhibited the increase of IL1-β tissue levels induced by Cg. Furthermore, bradykinin (BK)-, platelet activating factor (PAF)- and endothelin-1 (ET-1)-induced paw oedema were significantly inhibited by the HE or LRF while histamine- and substance P-induced paw oedema were unaffected. Finally, nirtetralin or phyltetralin caused inhibition of paw oedema induced by PAF or ET-1. These results show that the HE, the LRF and the lignans niranthin, phyltetralin and nirtetralin exhibited marked anti-inflammatory properties and suggest that these lignans seem to be the main active principles responsible for the anti-inflammatory properties reported for the HE of P. amarus.